MAY 01, 2022 6:01 PM PDT

Predicting Radiotherapy Resistance in Brain Metastases

WRITTEN BY: Alexandria Bass

Radiotherapy for brain metastasis can later cause neurocognitive decline. Sometimes this is a tradeoff when fighting brain cancer, but when patients don’t respond to radiation therapy, they experience this side effect of radiotherapy without any benefit. In a study published in Nature Medicine, researchers say they've found a way to predict who is most likely to be resistant to whole brain radiotherapy (WBRT) for brain metastasis.

The Spanish research team that published the study looked at mouse models and brain metastasis organotypic cultures from patients with radiotherapy resistance to examine factors involved in radiation therapy resistance. Patients who are said to be resistant to radiotherapy are those with tumor progression and recurrence of metastatic lesions despite receiving radiation.

Cancer metastasizes to the brain in anywhere from 20% to 40% of patients with solid tumors, usually in patients with lung cancer, breast cancer, or melanoma. While treatment of these metastases is shifting more towards targeted stereotactic radiosurgery, WBRT continues to be an important treatment option for these patients. 

Researchers from the study state the blood biomarker S100A9 may indicate if a patient will respond to WBRT. S100A9 is secreted by brain metastases. Activation of the S100A9-RAGE-NF-kB-JunB pathway in these metastases is thought to be a potential pathway of resistance to radiation treatments.

Manuel Valiente, PhD, the study's lead author, states, "I did not expect it to be that simple," in commenting on how easy it was to detect S100A9 in the blood. "But there is a correlation between the levels of S100A9 in the blood of patients and their resistance to radiotherapy."

From blood samples taken from 71 patients with brain metastases who had received WBRT, higher S100A9 levels in the blood were associated with poorer response to radiation treatments.

However, in the study's experimental models, the researchers also showed there is a way to restore sensitivity to radiation – through RAGE inhibitor FPS-ZM1. The authors suggest that concurrent use of RAGE inhibitors with WBRT may also minimize radiation side effects on normal brain tissue by lowering the amount of radiation needed to kill cancer cells.
 

Sources: Nature Medicine, Medscape

About the Author
BA in Psychology
Alexandria (Alex) is a freelance science writer with a passion for educating the public on health issues. Her other professional experience includes working as a speech-language pathologist in health care, a research assistant in a food science laboratory, and an English teaching assistant in Spain. In her spare time, Alex enjoys cycling, lap swimming, jogging, and reading.
You May Also Like
JUN 10, 2022
Immunology
Is Autoimmunity Related to Schizophrenia?
JUN 10, 2022
Is Autoimmunity Related to Schizophrenia?
Schizophrenia is estimated to impact around 24 million people, which is about 1 in 300 people worldwide. This poorly und ...
JUN 12, 2022
Neuroscience
High Optimism Linked to Living Past 90 in Women
JUN 12, 2022
High Optimism Linked to Living Past 90 in Women
Higher levels of optimism are linked to a longer lifespan and living beyond age 90 in women across diverse racial and et ...
JUN 19, 2022
Microbiology
Revealing the Origin & Spread of the Black Death
JUN 19, 2022
Revealing the Origin & Spread of the Black Death
Scientists have long sought to understand how Yersinia pestis, a gram-negative bacterium that causes plague, evolved int ...
JUN 23, 2022
Cell & Molecular Biology
This Protein Can Stop the Flu From Replicating
JUN 23, 2022
This Protein Can Stop the Flu From Replicating
When viral pathogens like influenza infect cells, they can take over the machinery in the host cells that have been infe ...
JUN 27, 2022
Genetics & Genomics
New detection method can locate DNA markers in advanced breast cancer within five hours
JUN 27, 2022
New detection method can locate DNA markers in advanced breast cancer within five hours
Breast cancer is the second most common cancer among women in the United States. For some alarming statistics, about 1 i ...
JUN 24, 2022
Drug Discovery & Development
Pain Medications with High Abuse Potential More Likely to Achieve Approval
JUN 24, 2022
Pain Medications with High Abuse Potential More Likely to Achieve Approval
Researchers found that pain medications with a high potential for abuse are more likely to be approved than medications ...
Loading Comments...